NCT02363140

Brief Summary

The menisci in the knee joint are important for normal functioning of the knee. Meniscus tears are amongst the commonest of injuries to the knee. The pattern and blood supply of the meniscus tears determines the treatment plan and outcome. The surgeon identifies the blood supply to the meniscus tear area during the arthroscopy(key hole operation) and decides the treatment option ie repair versus partial meniscectomy. This study aims to identify any changes that occur in the meniscus blood supply. The following are the main aims of the 'MOVE'study-

  1. 1.Use of non-invasive methods ie MRImaging to assess meniscus vascularity to preoperatively plan treatment and advice patient on recovery.
  2. 2.The study would assess changes in meniscus blood supply depending on age of the patient.
  3. 3.The study aims to assess the alteration in meniscus blood supply following an arthroscopic(key hole) meniscal repair operation.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 13, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Last Updated

February 19, 2016

Status Verified

February 1, 2016

Enrollment Period

3 years

First QC Date

February 9, 2015

Last Update Submit

February 18, 2016

Conditions

Keywords

Musculoskeletal System

Outcome Measures

Primary Outcomes (1)

  • Primary outcome is to assess meniscus vascularity in-vivo by use of MR imaging technique.

    6 months

Study Arms (4)

Group One patients in age group 18--20 years,

NO INTERVENTION

1. Patients should be aged 18--20 years or 35--45years 2. Asymptomatic knee for past 6 months. 3. Painless flexion-extension movements at knee joint.

Group Two patients in age group 35-45 years,

ACTIVE COMPARATOR

1. Patients should be aged 18--20 years or 35--45years 2. Asymptomatic knee for past 6 months. 3. Painless flexion-extension movements at knee joint.

Other: Will undergo a single MRI assessment with intravenous dye

Group Three Patients aged 75

ACTIVE COMPARATOR

1. Patients should be aged 75 or older 2. Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis 3. No clinical suspicion of meniscus tear 4. Painless flexion-extension movements at knee joint.

Other: Will undergo a single MRI assessment with intravenous dye

Group Four, any age due to undergo a surgical meniscus repair

ACTIVE COMPARATOR

1\. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair

Other: pre and post surgery MRI scan

Interventions

Group Three Patients aged 75Group Two patients in age group 35-45 years,
Group Four, any age due to undergo a surgical meniscus repair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients should be aged 18-20 years or 35-45years
  • Asymptomatic knee for past 6 months.
  • Painless flexion-extension movements at knee joint.
  • Patients should be aged 75 or older
  • Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis
  • No clinical suspicion of meniscus tear
  • Painless flexion-extension movements at knee joint.
  • \. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair.

You may not qualify if:

  • Proven Polyarthritis / Polyarthralgia secondary to Rheumatoid arthritis, Gout, Lupus, Ankylosing Spondylosis, Psoriatic arthritis
  • Any previous surgical procedure(open or arthroscopic) involving the knee joint.(baring the current meniscus repair in Group IV participants)
  • Patients unable to give informed consent.
  • Patients with contraindication for MR Imaging - Metal implants, prosthetic heart valves, pacemakers, metal foreign bodies, VP shunts, pregnancy, cochlear implant, metal clips in the brain, Patients with static tremor i.e. Parkinson's disease.
  • Patients with contraindications for contrast agent - Renal impairment, Previous allergic reaction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Lead

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsMetals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2015

First Posted

February 13, 2015

Study Start

June 1, 2012

Primary Completion

June 1, 2015

Last Updated

February 19, 2016

Record last verified: 2016-02